Biomoda and Clinical Research Center of Cape Cod Reach Agreement for Clinical Services
Under a collection protocol approved by an Institutional Review Board, CRCCCÂ will collect and provide samples necessary for Biomoda’s commercialization program of its non-invasive sputum assay for the early detection of lung cancer. CRCCC is a leading medical research firm with products and services that support the pharmaceutical, biotechnology, diagnostic and genomics industries
This entry was posted on Thursday, October 25th, 2007 at 9:09 am and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.